Crisis talks over drug’s danger


HEALTH chiefs, genetic experts, doctors and representatives of the pharmaceutical industry met in Madrid on Wednesday to hold a summit to discuss the growing safety fears over the controversial painkiller metamizole.
The crisis talks were held at the offices of the powerful medical regulator Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) and aimed at taking action to protect patients from dangerous side effects.
Research has shown northern Europeans – including British people – are among ‘at risk’ groups with an increased likelihood of developing agranulocytosis; a sudden and dangerous fall in white blood cells.

Read more in this week’s print edition or go to e-paper


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.